Business Context and Reporting Period
Pavmed Inc. (PAVM) filed this Form 8-K on September 8, 2022, to report the consummation of a second closing under a previously disclosed securities purchase agreement (SPA) for Senior Secured Convertible Notes.
Key Financial Metrics
- Debt Issuance: Sold an additional $11,250,000 in principal amount of Senior Secured Convertible Notes.
- Net Proceeds: Approximately $10.0 million after original issue discount and estimated offering expenses.
- Offering Expenses: No selling commissions; a 1.8% financial advisory fee was paid on gross proceeds.
- Use of Proceeds: Working capital and general corporate purposes.
- Total Offering Capacity: The SPA allows for up to $50,000,000 in total principal. An initial closing of $27,500,000 occurred on April 4, 2022.
Material Changes and Contractual Amendments
In connection with this closing, the Company entered into an Amendment and Waiver with the Investor, resulting in the following material changes to the SPA and Notes:
- ATM Facility: The SPA was amended to permit the sale of up to $5,000,000 in common stock via an "at the market" transaction.
- Equity Condition Revisions:
- Price Threshold: The VWAP of common stock must be at least $1.00 on any of the five trading days prior to determination and on more than four trading days during the 20 trading days prior.
- Volume Threshold: Aggregate daily dollar trading volume must be at least $2,000,000 on any of the five trading days prior and on more than four trading days during the 20 trading days prior.
- Waivers: The Investor waived the Equity Conditions for outstanding Notes, aligning them with the new conditions for additional Notes.
- Market Cap Covenant Waiver: Through March 5, 2023, the covenant limiting the ratio of Notes principal (plus interest/charges) to average market capitalization to 30% is waived, provided the ratio does not exceed 50% and market capitalization remains above $75 million.
Guidance, Outlook, and Risks
The filing does not provide specific financial guidance or forward-looking revenue projections. The primary risk factors relate to the terms of the Senior Secured Convertible Notes, including:
- Dividend restrictions and minimum available cash requirements.
- Events of default as defined in the Security Agreement.
- Conditions precedent for future closings, specifically the revised equity price and volume thresholds.
Investor Verification Checklist
- Verify the current market capitalization of Pavmed Inc. to ensure it remains above the $75 million threshold required for the covenant waiver.
- Review the trading volume and VWAP of PAVM stock over the last 20 trading days to assess eligibility for future closings under the revised Equity Conditions.
- Confirm the total outstanding principal of the Notes to monitor the 50% ratio cap relative to market capitalization.
- Examine the full text of the Security Agreement (Exhibit 10.2) for specific details on dividend restrictions and minimum cash requirements.